Patients with reflux esophagitis (grade II or III, Savary-Miller, intention-to-treat, n = 256, age range 19-82 years) were randomly assigned to a double-blind, double-dummy treatment with either pantoprazole 40 mg once daily or ranitidine 150 mg twice daily. After 4 weeks, each patient was clinically and endoscopically assessed. Failure to heal required a further 4 weeks of treatment and a new evaluation thereafter. After 4 weeks, healing of lesions was confirmed in 63% (69 out of 109) of patients receiving pantoprazole and in 22% (25 out of 113) receiving ranitidine (P < 0.001, per protocol population). After 8 weeks, the cumulative healing rates were 88% and 46%, respectively (P < 0.001). Complete freedom from esophagitis-related symptoms...
Background: Systematic assessments of the onset of symptom relief in the treatment of gastroesophage...
Patients with reflux esophagitis have a high rate of relapse within one year after therapy is discon...
Background: The presence of the gastric pathogen, Helicobacter pylori influences acid suppression by...
Marbachtalklinik, Bad Kissingen, Germany. BACKGROUND: Proton pump inhibiting drugs strongly decrease...
Background: Several clinical trials have shown that pantoprazole (40 mg) and omeprazole (40 or 20 mg...
Background: Gastroesophageal reflux disease (GERD) is a common chronic, relapsing condition that car...
OBJECTIVE: The aim of this study was to compare the effectiveness and tolerance of pantoprazole vers...
Background: Proton pump inhibitors can be effective as maintenance therapy in reducing the relapse r...
Proton pump inhibitors (PPIs) are the main drugs for the treatment of reflux esophagitis. Previous s...
Background: The objective of this study was to compare the efficacy of pantoprazole and esomeprazole...
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to he...
Proton pump inhibitors (PPIs) are the most effective anti secretory drugs available for controlling ...
Thirty two consecutive patients (age range 6 months-13.4 years) with severe reflux oesophagitis were...
Sixty patients who presented with erosive/ulcerative refractory reflux esophagitis were randomized t...
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to he...
Background: Systematic assessments of the onset of symptom relief in the treatment of gastroesophage...
Patients with reflux esophagitis have a high rate of relapse within one year after therapy is discon...
Background: The presence of the gastric pathogen, Helicobacter pylori influences acid suppression by...
Marbachtalklinik, Bad Kissingen, Germany. BACKGROUND: Proton pump inhibiting drugs strongly decrease...
Background: Several clinical trials have shown that pantoprazole (40 mg) and omeprazole (40 or 20 mg...
Background: Gastroesophageal reflux disease (GERD) is a common chronic, relapsing condition that car...
OBJECTIVE: The aim of this study was to compare the effectiveness and tolerance of pantoprazole vers...
Background: Proton pump inhibitors can be effective as maintenance therapy in reducing the relapse r...
Proton pump inhibitors (PPIs) are the main drugs for the treatment of reflux esophagitis. Previous s...
Background: The objective of this study was to compare the efficacy of pantoprazole and esomeprazole...
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to he...
Proton pump inhibitors (PPIs) are the most effective anti secretory drugs available for controlling ...
Thirty two consecutive patients (age range 6 months-13.4 years) with severe reflux oesophagitis were...
Sixty patients who presented with erosive/ulcerative refractory reflux esophagitis were randomized t...
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to he...
Background: Systematic assessments of the onset of symptom relief in the treatment of gastroesophage...
Patients with reflux esophagitis have a high rate of relapse within one year after therapy is discon...
Background: The presence of the gastric pathogen, Helicobacter pylori influences acid suppression by...